Geraldine Howard

TL;DR: In this paper, Norethisterone oenanthate (200 mg) was injected intramuscularly into four women and their plasma levels of radio-immunoassayable norethamerone, oestradiol and progesterone were measured.

TL;DR: Low-dose continuous chlormadinone acetate 0.5 mg may have a place in contraceptive practice for women who are lactating and wish to use an oral contraceptive, or for those who are spacing their families and are not over anxious about further pregnancies.

TL;DR: Pardthaisong et al. as mentioned in this paper showed that fertility is not impaired once the progestogen is cleared from the body, even after discontinuation of injectable contraceptives.

TL;DR: The extent of suppression of gonadotrophins varied between the subjects (from 30–75% of control values for FSH and from 50–80% for LH), but the degree of suppression in any one subject was similar, and in these women plasma levels of norethisterone had declined to undetectable values within eight weeks of injection.

TL;DR: There was no significant effect on the intravenous glucose tolerance, prothrombin time, or on plasma coagulation factors VII and X, further confirming the safety of norethisterone oenanthate when used as a short‐term injectable contraceptive.